ECU
ELV icon

Egerton Capital (UK)’s Elevance Health ELV Stock Holding History

Egerton Capital (UK)’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-694,185
Closed -$199M – 33
2019
Q1 		$199M Buy
694,185
+443,428
+177% +$128M 1.41% 23
2018
Q4 		$65.9M Buy
+250,757
New +$69M 0.55% 25

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Egerton Capital (UK)'s ELV Position: Q2 2019 in Review

Egerton Capital (UK) sold out of Elevance Health (ELV) in Q2 2019, closing a stake of 694,185 shares — an estimated $199M sold.

Egerton Capital (UK) first reported a position in ELV in Q4 2018 and held it in 2 quarters. The position peaked at $199M in Q1 2019. 1,030 funds tracked by Wall St. Rank hold ELV as of Q2 2019.

  • Egerton Capital (UK) reported no remaining Elevance Health position as of Q2 2019 after selling out during the quarter.
  • Egerton Capital (UK) sold 694,185 Elevance Health shares in Q2 2019, an estimated $199M.
  • Egerton Capital (UK) first reported a position in Elevance Health in Q4 2018 and held it in 2 quarters.
  • Egerton Capital (UK)'s Elevance Health position peaked at $199M in Q1 2019.
  • 1,030 funds tracked by Wall St. Rank held Elevance Health as of Q2 2019.

Based on Egerton Capital (UK)'s 13F filing for Q2 2019, filed 13 Aug 2019.